Buprenorphine Extended-Release Injection and Dihydroergotamine nasal
Determining the interaction of Buprenorphine Extended-Release Injection and Dihydroergotamine nasal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Extended-Release Injection-Dihydroergotamine Nasal Spray
- Buprenorphine Extended-Release Injection-Dilacor XR
- Buprenorphine Extended-Release Injection-Dilantin
- Buprenorphine Extended-Release Injection-Dilantin Infatabs
- Buprenorphine Extended-Release Injection-Dilantin injection
- Buprenorphine Extended-Release Injection-Dilantin Kapseals
- Dihydroergotamine nasal-Buprenorphine implant
- Dihydroergotamine nasal-Buprenorphine Injection
- Dihydroergotamine nasal-Buprenorphine injection - Buprenex
- Dihydroergotamine nasal-Buprenorphine injection - Sublocade
- Dihydroergotamine nasal-Buprenorphine Intradermal
- Dihydroergotamine nasal-Buprenorphine oral/buccal